Massachusetts Governor Maura H. Healey announced the nomination of three new commissioners on the Cannabis Control Commission of the Commonwealth (CCC) in May 2026. The CCC is a central agency for the State. Massachusetts cannabis regulation. The appointments come after the passage of comprehensive reforms to the cannabis laws in the State last month. These measures aim at strengthening oversight, improving accountability and supporting the development of this industry.
Christopher Harding has been appointed as the chair, Xiomara deLobato and Anthony Wilson. The Governor Healey said that this industry is a major contributor to Massachusetts’ economy. It supports thousands of small businesses and jobs. These reforms will establish a more effective and accountable regulatory system that can meet the needs of a rapidly growing industry.
Cannabis Control Commission Restructuring
Massachusetts Cannabis policy has been updated significantly since initial legalization. The Cannabis Control Commission has been restructured as a primary reform. The Cannabis Control Commission, which was formerly a five member body, will operate now as a commission of three members.
The new law is important in that it designates the CCC Chair as CEO. This new law gives the CCC Chair direct authority to make decisions about day-to-day activities, including staffing and budgeting. The purpose of this structural change is to improve operational management and create a clearer leader within the Commission. It aims for greater integrity, stability and public confidence in Massachusetts Cannabis Regulation.
New Leadership Profiles
- Christopher Harding, Chairperson: Harding, who was appointed chair of the board in January 2016, brings a wealth of leadership expertise from his time spent working for both government agencies and private companies. Ses background is in organization management, strategy operations and technology modernization. He is currently Chief of Staff and the Undersecretary of the Executive Office of Health and Human Services. He previously served as Commissioner of Massachusetts Department of Revenue. Harding is also a member of Cannabis Advisory Board and chaired its industry subcommittee.
- Xiomara DeLobato (Commissioner): DeLobato brings to the Commission expertise in economic development, social justice, workforce strategy and community engagement. She is the current Vice President of Western Massachusetts Economic Development Council and its Chief of Staff. She has a diverse background in higher education, non-profit leadership and public service. Her focus is on increasing opportunities for communities, including underserved groups, as well as fostering links between them and economic growth. She was appointed as Social Equity Commissioner.
- Anthony Wilson (Commissioner), Wilson brings a wealth of experience to the table in areas such as cannabis law, local government and business development. He’s advised cannabis operators, startups, and entrepreneurs on how to navigate Massachusetts’ regulatory landscape. Wilson’s private practice is complemented by his work with UMass Boston, where he has been involved in economic development projects and organization management. He also served as a senior leader for the Springfield and Cambridge municipalities, serving both as Associate City Solicitor and Cambridge City Clerk.
Industry impact and key regulatory reforms
Reform legislation, in addition to structural changes, modernizes Massachusetts cannabis regulations to support workers, businesses and consumers. Key provisions include:
- Expanded Licensing This law increases the retail license cap and allows for new categories of licenses. The law authorizes new license categories, including event-based, research, and restricted delivery. These licenses are designed to increase market access and participation.
- Latest Updates on Medical Marijuana: The announcement did not provide specifics about the changes made to requirements for businesses that sell medical marijuana.
- Financial Accountability: Unpaid business debts in the sector have now been addressed with stronger protections for financial accountability.
- Future Studies: Commission directed to carry out further research on trends in cannabis usage, taxation policy and future regulation for hemp-derived products containing cannabinoids. The Commission is taking a proactive stance in response to the changing market dynamics.
This collective reform is designed to create a cannabis market that’s safer, more transparent, competitive, and innovative.
Disclaimer: The information contained in this article is not intended to be a substitute for medical advice. Hemp Gazette makes no medical diagnoses or recommendations. Consult a healthcare professional before you make any decision regarding your health. Therapeutic Goods Administration of Australia has not evaluated statements about the therapeutic benefits of cannabinoids, hemp or cannabis. TGA regulates the access to medical cannabis in Australia.